Brief: Neubase Therapeutics Reports Financial Results For The Third Quarter Of Fiscal Year 2021 And Recent Operating Highlights
12/08/2021 21:46
Aug 12 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
THIRD
QUARTER OF FISCAL YEAR 2021 AND RECENT OPERATING HIGHLIGHTS
* Q3 LOSS PER SHARE $0.29
* Q3 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX8sFjxS
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet